Suppr超能文献

解析嗅鞘母细胞瘤嗅上皮发育途径。

Deconstructing Olfactory Epithelium Developmental Pathways in Olfactory Neuroblastoma.

机构信息

Medical Scientist Training Program, Duke University School of Medicine, Durham, North Carolina.

Department of Head and Neck Surgery & Communication Sciences, Duke University, School of Medicine, Durham, North Carolina.

出版信息

Cancer Res Commun. 2023 Jun 6;3(6):980-990. doi: 10.1158/2767-9764.CRC-23-0013. eCollection 2023 Jun.

Abstract

UNLABELLED

Olfactory neuroblastoma is a rare tumor arising from the olfactory cleft region of the nasal cavity. Because of the low incidence of this tumor, as well as an absence of established cell lines and murine models, understanding the mechanisms driving olfactory neuroblastoma pathobiology has been challenging. Here, we sought to apply advances from research on the human olfactory epithelial neurogenic niche, along with new biocomputational approaches, to better understand the cellular and molecular factors in low- and high-grade olfactory neuroblastoma and how specific transcriptomic markers may predict prognosis. We analyzed a total of 19 olfactory neuroblastoma samples with available bulk RNA-sequencing and survival data, along with 10 samples from normal olfactory epithelium. A bulk RNA-sequencing deconvolution model identified a significant increase in globose basal cell (GBC) and CD8 T-cell identities in high-grade tumors (GBC from ∼0% to 8%, CD8 T cell from 0.7% to 2.2%), and significant decreases in mature neuronal, Bowman's gland, and olfactory ensheathing programs, in high-grade tumors (mature neuronal from 3.7% to ∼0%, Bowman's gland from 18.6% to 10.5%, olfactory ensheathing from 3.4% to 1.1%). Trajectory analysis identified potential regulatory pathways in proliferative olfactory neuroblastoma cells, including PRC2, which was validated by immunofluorescence staining. Survival analysis guided by gene expression in bulk RNA-sequencing data identified favorable prognostic markers such as SOX9, S100B, and PLP1 expression.

SIGNIFICANCE

Our analyses provide a basis for additional research on olfactory neuroblastoma management, as well as identification of potential new prognostic markers.

摘要

未加标签

嗅神经母细胞瘤是一种罕见的肿瘤,起源于鼻腔嗅裂区。由于这种肿瘤的发病率较低,以及缺乏已建立的细胞系和小鼠模型,理解驱动嗅神经母细胞瘤病理生物学的机制一直具有挑战性。在这里,我们试图将人类嗅上皮神经发生龛的研究进展,以及新的生物计算方法应用于更好地理解低级别和高级别嗅神经母细胞瘤的细胞和分子因素,以及特定的转录组标记如何预测预后。我们分析了总共 19 个具有可用批量 RNA 测序和生存数据的嗅神经母细胞瘤样本,以及 10 个来自正常嗅上皮的样本。批量 RNA 测序去卷积模型在高级别肿瘤中鉴定出显著增加的球状基底细胞(GBC)和 CD8 T 细胞身份(GBC 从约 0%增加到 8%,CD8 T 细胞从 0.7%增加到 2.2%),并且在高级别肿瘤中显著降低成熟神经元、布曼氏腺和嗅鞘细胞程序(成熟神经元从 3.7%降至约 0%,布曼氏腺从 18.6%降至 10.5%,嗅鞘细胞从 3.4%降至 1.1%)。轨迹分析鉴定了增殖性嗅神经母细胞瘤细胞中的潜在调控途径,包括 PRC2,其通过免疫荧光染色得到验证。基于批量 RNA 测序数据中的基因表达进行的生存分析确定了有利的预后标志物,如 SOX9、S100B 和 PLP1 表达。

意义

我们的分析为嗅神经母细胞瘤管理的进一步研究以及潜在新的预后标志物的鉴定提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988e/10243222/e93b7c21afe7/crc-23-0013_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验